Effect of Cinnamon on Glucose and Lipid Levels in Non-Insulin Dependent Type 2 Diabetes Mellitus
NCT00237640 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 85
Last updated 2008-09-22
Summary
The purpose of this study is to determine the effects of cinnamon on serum glucose and lipid levels in people with non-insulin dependent type 2 diabetes mellitus.
Conditions
- Diabetes Mellitus, Adult Onset
Interventions
- DRUG
-
Cinnamon or placebo 500 mg capsule twice daily
Cinnamon 500 mg capsule twice daily or placebo capsule twice daily
Sponsors & Collaborators
-
National Center for Research Resources (NCRR)
collaborator NIH -
University of Oklahoma
lead OTHER
Principal Investigators
-
Steve M Blevins, M.D. · University of Oklahoma
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- DOUBLE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2005-03-31
- Primary Completion
- 2007-07-31
- Completion
- 2007-07-31
Countries
- United States
Study Locations
More Related Trials
-
Investigation of Cinnamon Spice on Glucose Tolerance in Subjects With Pre-diabetes
NCT04342624 ·Status: COMPLETED ·Phase: NA
-
Effect Cinnamon Spice on Postprandial Glucose and Insulin Responses
NCT04686552 ·Status: COMPLETED ·Phase: NA
-
Cinnamon Bark, Water-Soluble Cinnamon Extract, and Metformin for Treatment of Type 2 DM.
NCT01302743 ·Status: TERMINATED ·Phase: NA
-
Is There a Metabolic Effect of Cinnamon on HbA1c, Blood Pressure and Serum Lipids in Type 2 Diabetes Mellitus?
NCT00846898 ·Status: COMPLETED ·Phase: PHASE2
-
Effect of Cinnamon Extract on Insulin Resistance in Polycystic Ovary Syndrome
NCT00970541 ·Status: TERMINATED ·Phase: PHASE1
-
Bioavailability Study of Cinnamon in Healthy Subjects
NCT01847053 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Effect of Aqueous Cinnamon Extract on the Postprandial Glycaemia Levels in Type 2 Diabetes Mellitus
NCT05145673 ·Status: COMPLETED ·Phase: NA
-
Effect of Oral Cinnamon Intervention in Metabolic Syndrome
NCT02455778 ·Status: COMPLETED ·Phase: NA
-
Improving Insulin Resistance in Gynecological Cancer Patients
NCT04139694 ·Status: WITHDRAWN ·Phase: NA
-
Effect of Cinnamomum Zeylanicum on Glycemic Levels of Adult Patients With Type 2 Diabetes
NCT04023539 ·Status: COMPLETED ·Phase: NA
-
Berberine and Cinnamon in Management of Diabetes
NCT05570357 ·Status: COMPLETED ·Phase: NA
-
Effect of Nutritional Products in Subjects With Type 2 Diabetes
NCT02923960 ·Status: COMPLETED ·Phase: NA
-
The Effect of Cinnamon on HbA1c Among Adolescents With Type I Diabetes
NCT00371800 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Effects of Curcumin Supplementation on Lipid Profile and Inflammatory Markers of Patients With Type 2 Diabetes
NCT02529969 ·Status: UNKNOWN ·Phase: PHASE2/PHASE3
-
Effects of Curcumin on Postprandial Blood Glucose, and Insulin in Healthy Subjects
NCT01029327 ·Status: COMPLETED
-
A Human Clinical Trial Evaluating the Effect of MealShape™ on Blood Glucose Level Following Consumption of Standard Meal
NCT02074423 ·Status: COMPLETED ·Phase: NA
-
Cocoa Polyphenols and Postprandial Metabolism in Type 2 Diabetes
NCT01886989 ·Status: COMPLETED ·Phase: NA
-
Glycemic Index in Subjects With Diabetes Mellitus Insulin Requesting
NCT02881164 ·Status: COMPLETED ·Phase: NA
-
Curcumin Supplementation and Patients With Type 2 Diabetes
NCT02529982 ·Status: COMPLETED ·Phase: NA
-
Glycemic Response to Oral Nutrition Supplements
NCT02612675 ·Status: COMPLETED ·Phase: NA
-
Experimental Studies of the Effects of Caffeine on Glucose Regulation
NCT00432887 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
Effects of Nutritional Products on Blood Glucose in Subjects With Type 2 Diabetes
NCT00753181 ·Status: COMPLETED ·Phase: PHASE3
-
Effect of High Monounsaturated Fat Diet on Glycemic Control and Cardiovascular Risk Factors in Type 2 Diabetes
NCT00622960 ·Status: COMPLETED ·Phase: PHASE1
-
Association Between Natural Hypoglycemic Foods and Blood Sugar Level: A Pilot Study
NCT05272839 ·Status: UNKNOWN ·Phase: NA
-
Curcumin Supplementation for the Improvement of Diabetes-related Outcomes
NCT06984640 ·Status: COMPLETED ·Phase: NA